Author:
Hussien Hani,Nastasa Andra,Apetrii Mugurel,Nistor Ionut,Petrovic Mirko,Covic Adrian
Abstract
Abstract
Background
Older adults at a higher risk of adverse outcomes and mortality if they get infected with Severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2). These undesired outcomes are because ageing is associated with other conditions like multimorbidity, frailty and disability. This paper describes the impact of frailty on coronavirus disease 2019 (COVID-19) management and outcomes. We also try to point out the role of inflamm-ageing, immunosenescence and reduced microbiota diversity in developing a severe form of COVID-19 and a different response to COVID-19 vaccination among older frail adults. Additionally, we attempt to highlight the impact of frailty on intensive care unit (ICU) outcomes, and hence, the rationale behind using frailty as an exclusion criterion for critical care admission. Similarly, the importance of using a time-saving, validated, sensitive, and user-friendly tool for frailty screening in an acute setting as COVID-19 triage.
We performed a narrative review. Publications from 1990 to March 2021 were identified by searching the electronic databases MEDLINE, CINAHL and SCOPUS.
Based on this search, we have found that in older frail adults, many mechanisms contribute to the severity of COVID-19, particularly cytokine storm; those mechanisms include lower immunological capacity and status of ongoing chronic inflammation and reduced gut microbiota diversity.
Higher degrees of frailty were associated with poor outcomes and higher mortality rates during and after ICU admission. Also, the response to COVID-19 vaccination among frail older adults might differ from the general population regarding effectiveness and side effects.
Researches also had shown that there are many tools for identifying frailty in an acute setting that could be used in COVID-19 triage, and before ICU admission, the clinical frailty scale (CFS) was the most recommended tool.
Conclusion
Older frail adults have a pre-existing immunopathological base that puts them at a higher risk of undesired outcomes and mortality due to COVID-19 and poor response to COVID-19 vaccination. Also, their admission in ICU should depend on their degree of frailty rather than their chronological age, which is better to be screened using the CFS.
Publisher
Springer Science and Business Media LLC
Subject
Geriatrics and Gerontology
Reference110 articles.
1. JHU. How does mortality differ across countries? : John Hopkins Coronavirus resource Centre 2020 [Available from: https://coronavirus.jhu.edu/data/mortality. [accessed 2020 July 26].
2. ESSy. Surveillance of COVID-19 at longterm care facilities in the EU/EEA. 2020 [Available from: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-long-term-care-facilities-surveillance-guidance.pdf. [accessed 2022 July 22].
3. Cohen JF, Korevaar DA, Matczak S, Brice J, Chalumeau M, Toubiana J. COVID-19-related mortality by age groups in Europe: A meta-analysis. medRxiv. 2020.
4. ONS. Deaths involving coronavirus (COVID-19) UK: Office for national statistics; 2021 [cited 2021 February 2021]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights#deaths. [accessed 2021 21.02.2021].
5. CDC. Provisional COVID-19 Death Counts by Age. 2021 [cited 2021 February 21]. Available from: https://data.cdc.gov/NCHS/Provisional-COVID-19-Death-Counts-by-Sex-Age-and-W/vsak-wrfu/data. [].
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献